Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance & Compliance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
      • Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • Email Alerts
      • Contact IR

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance & Compliance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
      • Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR

Presentations

Presentations

April 25, 2022
Kempen Conference Presentation
March 16, 2022
Publication of full year results 2021
March 15, 2022
MP Corporate Presentation
January 12, 2022
JP Morgan 40th Annual Virtual Healthcare Conference Presentation
January 10, 2022
HC Wainwright Healthcare Conference Presentation
January 10, 2022
Ensovibep Clinical Results Call Presentation
December 15, 2021
Oncology Day 2021 Presentation
November 17, 2021
MP Corporate Presentation
October 20, 2021
Pre-clinical data of ensovibep, a multi-specific DARPin therapeutic with high potency against all frequent SARS-CoV-2 variants
August 26, 2021
H1 2021 Results and Corporate Update

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page next ›
  • Last page last »

Investors

> Sidebar Menu

  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Scientific Documents
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance & Compliance
    • Documents & Charters
    • Management Team & Board of Directors
    • Committee Composition
    • Major Shareholders
    • Management Transactions
    • Compliance
  • Financials & Filings
    • SEC Filings
    • Financial Reports
  • General Meeting
  • IR Resources
    • Email Alerts
    • Contact IR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2022 Molecular Partners.